Xylitol for Chronic Sinusitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

July 16, 2018

Study Completion Date

July 16, 2018

Conditions
Chronic RhinosinusitisRhinosinusitisSinusitisDrain SinusEndoscopic Sinus SurgeryBiofilmsBacterial Overgrowth
Interventions
DRUG

Xylitol

Topical 5% Xylitol (wt/vol) diluted in saline nasal irrigant. Topical corticosteroid and antibiotic as directed by bacterial DNA sequencing results will be diluted in this irrigant and administered concurrently.

DRUG

Saline

Saline as a standard-of-care nasal irrigant. Topical corticosteroid and antibiotic as directed by bacterial DNA sequencing results will be diluted in this irrigant and administered concurrently.

Trial Locations (1)

70121

Ochsner Medical Center, New Orleans

Sponsors
All Listed Sponsors
collaborator

Tulane University School of Medicine

OTHER

lead

Ochsner Health System

OTHER

NCT03229551 - Xylitol for Chronic Sinusitis | Biotech Hunter | Biotech Hunter